Molecular test confirms antimalarial antibody’s efficacy
On Jun. 18, 2025, researchers at the University of Washington (UW) School of Medicine announced that a highly…
Biotechnology | CDC | FDA | HIV | Infectious Disease | Medicine | Therapeutics
Yeztugo® (Lenacapavir) Is the First and Only FDA-Approved HIV Prevention Option Offering 6 Months of Protection
On Jun. 18, 2025, Gilead Sciences announced that the U.S. Food and Drug Administration (FDA) has approved Yeztugo®…
Nvidia-backed AI startup SandboxAQ creates new data to speed up drug discovery
On Jun. 18, 2025, SandboxAQ, an artificial intelligence startup spun out of Alphabet’s Google and backed by Nvidia…
Deadly listeria outbreak linked to chicken alfredo fettucine sold at Kroger and Walmart
On Jun. 18, 2025, federal health officials announced a listeria food poisoning outbreak that has killed three people…
Biotechnology | CDC | Diagnostics | Infectious Disease | Measles | Vaccine
Wastewater testing reveals measles virus in New Mexico sample
On Jun. 17, 2025, the New Mexico Department of Health (NMDOH) announced that wastewater in Deming has tested…
WHO Reports Higher Incidence of Cholera in Ongoing Outbreak
On Jun. 17, 2025, the World Health Organization (WHO) reported that from January 1, 2025 to May 25,…
Lilly to acquire Verve Therapeutics for $1 billion to advance one-time treatments for people with high cardiovascular risk
On Jun. 17, 2025, Eli Lilly and Verve Therapeutics, a Boston-based clinical-stage company developing genetic medicines for cardiovascular…
Texas Reports Six New Measles cases in West Texas
On Jun. 17, 2025, the Texas Department of State Health Services (DSHS) reported a total of 750 cases…
Supernus Pharmaceuticals to Acquire Sage Therapeutics
On Jun. 16, 2025, Supernus Pharmaceuticals and Sage Therapeutics announced a definitive agreement for Supernus to acquire Sage…
Scientists can now target the cells at the center of ALS
On Jun. 16, 2025, the Allen Institute announced that for the first time ever, scientists have developed a…
BrainStorm Announces New Survival Data from Access Program Cohort: Remarkably 90% of ALS Patients Survived Over 5 Years with NurOwn
On Jun. 16, 2025, BrainStorm Cell Therapeutics announced new survival data from 10 participants in its Expanded Access…
‘Artificial pancreas’ transforming the lives of thousands of children and young people with type 1 diabetes
On Jun. 16, 2025, the National Institute for Health and Care Excellence (NICE) announced that the recommendation in…
Purdue Pharma $7.4 billion opioid settlement wins broad support from US states
On Jun. 16, 2025, Purdue Pharma has won support from the attorneys general of 55 U.S. states and…
Japan draws up $700 Million Fund to attract foreign researchers
On Jun. 13, 2025, the Japanese government unveiled a 100 billion yen ($700 million) policy package designed to…
Biotechnology | Disease | Medicine | Oncology | Therapeutics
UK Nice leads the way in approving breakthrough treatment for multiple myeloma
On Jun. 13, 2025, people in England will become the first in the world to receive belantamab mafodotin…
Tiny human hearts grown in pig embryos for the first time
On Jun. 13, 2025, researchers reported growing hearts containing human cells in pig embryos for the first time….
Pioneering cancer plasticity atlas will help predict response to cancer therapies
On Jun. 12, 2025, the Wellcome Sanger Institute, Parse Biosciences and the Computational Health Center at Helmholtz Munich…
Moderna Receives U.S. FDA Approval for RSV Vaccine, mRESVIA, in Adults Aged 18–59
On Jun. 12, 2025, Moderna announced that the U.S. Food and Drug Administration (FDA) has approved mRESVIA® (mRNA-1345),…
COVID-19 | Diagnostics | FDA | HIV | Infectious Disease | Influenza | Measles | NIH | Plague | Polio | Vaccine
Kennedy replaces fired U.S. CDC panel members, includes anti-vaccine proponents
On Jun. 12, 2025, U.S. Health Secretary Robert Kennedy Jr. named eight members to serve on a key…
Scientists map the first step in Alzheimer’s protein aggregation and discover clues for future therapies
On Jun. 11, 2025, researchers from the Wellcome Sanger Institute, Centre of Genomic Regulation (CRG) and Institute for…
Twenty Measles Cases Confirmed in Montana
On Jun. 11, 2025, the Montana Department of Public Health and Human Services (DPHHS) reported a total of…
Iowa Health Officials Confirm Third Measles Case in the State
On Jun. 11, 2025, The Iowa Department of Health and Human Services (HHS) is reporting the state’s third…
Novavax’s COVID-19-Influenza Combination and Stand-alone Influenza Vaccine Candidates Showed Robust Immune Responses in Phase 3 Trial
On Jun. 11, 2025, Novavax announced results of the initial cohort of its COVID-19-Influenza Combination (CIC) and stand-alone trivalent…
First-of-its-kind technology helps man with ALS ‘speak’ in real time
On Jun. 11, 2025, researchers at the University of California, Davis, announced they have developed an investigational brain-computer…
More Measles cases Reported in Central Texas
On Jun. 10, 2025, the Texas Department of State Health Services (DSHS) reported 744 cases of measles have…
2 patient cases of Legionella pneumonia reported
On Jun. 10, 2025, two patients treated within the past two months at the University of Washington Medical…
CDC | COVID-19 | FDA | Infectious Disease | Influenza | Measles | NIH | U.S. Congress | Vaccine | Women's Health
US Health Secretary Kennedy guts vaccine advisory committee
On Jun. 9, 2025, Health and Human Services Secretary Robert F. Kennedy Jr. has fired all 17 members…
Measles Exposure Site Confirmed in Oakland County, Michigan
On Jun. 9, 2025, Oakland County Health Division in Michigan is notifying the public about a measles exposure…
WHO says Mpox is an Ongoing health emergency
On Jun. 9, 2025, the World Health Organization (WHO) said the mpox outbreak is still a public health…
U.S. FDA Approves Merck’s ENFLONSIA™ (clesrovimab-cfor) for Prevention RSV Lower Respiratory Tract Disease in Infants
On Jun. 9, 2025, Merck announced the U.S. Food and Drug Administration (FDA) has approved ENFLONSIA™ (clesrovimab-cfor) for…